Market Overview:

The global obesity treatment market is segmented by product type, delivery method, distribution channel, and region. By product type, the market is segmented into medications, devices, and surgery. Medications are the largest segment of the market, and are expected to continue to grow during the forecast period. The increasing demand for effective and safe weight-loss medications is driving the growth of this segment.

Obesity Treatment Market size is expected to be worth around US$ 15,087 Mn by 2032 from US$ 5649.5 Mn in 2022, growing at a CAGR of  10.6% during the forecast period from 2023 to 2032.According to the World Health Organization (WHO), over 1.9 billion adults were overweight or obese in 2016. Obesity is a major risk factor for chronic diseases such as type 2 diabetes, cardiovascular disease, and some types of cancer.

– Please check this report :@https://market.us/report/obesity-treatment-market/

Market key Takeways:

  • The increasing prevalence of obesity and the rising incidence of obesity-related chronic diseases are the major factors driving the growth of the market.
  • Medications are the largest segment of the market, and are expected to continue to grow during the forecast period.
  • Oral medications are the most common type of weight-loss medication, and are expected to remain the dominant segment during the forecast period.
  • Injectable medications are gaining popularity due to their effectiveness and convenience.
  • Implantable medications are still in the early stages of development, but are expected to grow in the future.
  • Hospitals are the largest distribution channel for obesity treatments, and are expected to remain the dominant segment during the forecast period.

Market Key Players:

  • Arena Pharmaceuticals, Inc.
  • USGI Medical, Inc.
  • Johnson & Johnson Services, Inc.
  • Arena Pharmaceuticals Inc.
  • Allergan Plc
  • Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • Bausch Health Companies Inc.
  • VIVUS LLC
  • Other key players

Regional Analysis:

-North America [United States, Canada, Mexico]
-South America [Brazil, Argentina, Columbia, Chile, Peru]
-Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
-Middle East & Africa [GCC, North Africa, South Africa]
-Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]mailto:inquiry@market.us

Market Top Segmentations:

Surgery Type

  • Adjusting Gastric Banding
  • Biliopancreatic Diversion with Duodenal Switch
  • Sleeve Gastrectomy
  • Roux-en-Y Gastric Bypass
  • Other Surgery Types

 Drug Types

  • Combination Drugs
  • Appetite Suppressants
  • Malabsorption
  • Satiety

End-User

  • Hospitals
  • Clinics

Make an inquiry before picking up this report @https://market.us/report/obesity-treatment-market/#inquiry

Market Challenges:

  • The high cost of obesity treatments.
  • The lack of reimbursement for obesity treatments by insurance companies.
  • The side effects of obesity treatments.
  • The difficulty of maintaining weight loss after treatment.
  • The stigma associated with obesity.

Contact:

Global Business Development Team – Market.us

Market.us (Powered by Prudour Pvt. Ltd.)

Send Email: inquiry@market.us

Address: 420 Lexington Avenue, Suite 300 New York City, NY 10170, United States

Tel: +1 718 618 4351

Website: https://market.us